Baylor College of Medicine is collaborating with VistaGen Therapeutics, Inc. on a study of the anti-suicidal effects of a new VistaGen drug candidate in healthy veteran volunteers.
Puzzled by their experimental results, a team of scientists investigated why a research tool that was expected to suppress neuronal activity actually was stimulating it.
Researchers identify estrogen receptor alpha gene (ESR1) translocation events that drive not only therapeutic resistance, but also trigger ER+ breast cancer cells to metastasize.
Researchers at Baylor College of Medicine have identified a potential strategy for treating osteoarthritis from both a symptomatic and disease-modifying perspective by using gene therapy to inhibit the interleukin-1 pathway.
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
The Latin American nonprofit Fundación Carlos Slim has awarded Dr. María Elena Bottazzi the 2018 Research Trajectory Slim Health Award for her 20-year work developing vaccines for parasitic diseases.
The Translational Research Institute for Space Health (TRISH) funds groundbreaking research and development that can reduce the risks to the health and performance of humans on space exploration missions.
